Search - tctmd.com

Displaying 301 - 320 of 349

Sort: Relevancy | Date

Presentation NY Valves 2025

Correction of Doppler Gradients for LVOT Flow and Pressure Recovery Following Balloon-Expandable TAVR

Presenter: Muhammad Suleman

June 25, 2025

Presentation NY Valves 2025

Late Health Status Outcomes with Patient-Prosthesis Mismatch After AVR in the PARTNER Trials

Presenter: Yasser M. Sammour

June 25, 2025

Presentation NY Valves 2025

First in Human Study of the Microtech Novel Implantable Pressor Sensor in LVAD Patients

Presenter: Nir Uriel

June 25, 2025

Presentation NY Valves 2025

Keynote: Treatment Advances in Obstructive HCM with Drugs, Catheters and Surgery: Putting It All Together in 2025

Presenter: Martin Maron

June 25, 2025

Presentation NY Valves 2025

Right Heart Remodeling Following TTVR With the VDyne System: Results From the VISTA EFS Program

Presenter: Nadira Hamid

June 25, 2025

Presentation NY Valves 2025

Mimicking Surgical Myotomy: Evolution of A Transcatheter Approach to Relieve Outflow Obstruction (SESAME)

Presenter: Adam B. Greenbaum

June 25, 2025

Presentation NY Valves 2025

30-Day Outcomes of the Lux-Plus TTVR System in Large Tricuspid Annuli in the TRINITY Trial

Presenter: Thomas Elie Modine

June 25, 2025

Presentation NY Valves 2025

Progress in Surgery: Emergence of the Transapical Beating Heart Myectomy

Presenter: Juan B. Grau

June 25, 2025

Presentation NY Valves 2025

Early Feasibility Experience of Posterior Leaflet Restoration to Reduce Secondary MR Using the MRace Implant (EXPLORE MR)

Presenter: Fabio Sandoli de Brito

June 25, 2025

Presentation NY Valves 2025

Impact of Myosin Inhibitors on Cardiac Remodeling in HCM: Different from Septal Reduction Therapies?

Presenter: Shepard D. Weiner

June 25, 2025

Presentation NY Valves 2025

A Contemporary View on Pathophysiology and Clinical Significance of LVOT in HCM

Presenter: Anjali Owens

June 25, 2025

Presentation NY Valves 2025

SIEGEL TAVR: FIH 1 year & US Early Feasibility 30 Day Results

Presenter: Pradeep K. Yadav

June 25, 2025

Presentation NY Valves 2025

SESAME for the Treatment of Subaortic Membrane: First-in-Human Series

Presenter: Yasemin Ciftcikal

June 25, 2025

Presentation NY Valves 2025

Advantages of Splitting Bicuspid Aortic Valve Leaflets Prior to TAVR: A New Paradigm for Leaflet Modification in BAV?

Presenter: Hasan Jilaihawi

June 25, 2025

Presentation NY Valves 2025

BONAPART: A Novel Mechanical Leaflet Splitting Device

Presenter: Eberhard Grube

June 25, 2025

Presentation NY Valves 2025

The Evolution of Leaflet Modification Technologies: Emerging Techniques (e.g. UNICORN, BATMAN, etc), Technologies and Future Applications

Presenter: Jaffar M. Khan

June 25, 2025

Presentation NY Valves 2025

M-TEER for Atrial and Ventricular SMR: Insights from the REPAIR Study

Presenter: Philipp von Stein

June 25, 2025

Presentation NY Valves 2025

Clipping Strategies and Outcomes in Atrial SMR Patients Treated with the MitraClip System

Presenter: Mark J. Ricciardi

June 25, 2025

Presentation NY Valves 2025

Effect of TTVR on Preference-Weighted Health Status: A Patient-Centered Sub-Study of the TRISCEND II Pivotal Trial

Presenter: Suzanne V. Arnold

June 25, 2025

Presentation NY Valves 2025

Early Outcomes of Real-World TTVR (Evoque)

Presenter: Fabien Praz

June 25, 2025

Advertisement

Correction of Doppler Gradients for LVOT Flow and Pressure Recovery Following Balloon-Expandable TAVR

Late Health Status Outcomes with Patient-Prosthesis Mismatch After AVR in the PARTNER Trials

First in Human Study of the Microtech Novel Implantable Pressor Sensor in LVAD Patients

Keynote: Treatment Advances in Obstructive HCM with Drugs, Catheters and Surgery: Putting It All Together in 2025

Right Heart Remodeling Following TTVR With the VDyne System: Results From the VISTA EFS Program

Mimicking Surgical Myotomy: Evolution of A Transcatheter Approach to Relieve Outflow Obstruction (SESAME)

30-Day Outcomes of the Lux-Plus TTVR System in Large Tricuspid Annuli in the TRINITY Trial

Progress in Surgery: Emergence of the Transapical Beating Heart Myectomy

Early Feasibility Experience of Posterior Leaflet Restoration to Reduce Secondary MR Using the MRace Implant (EXPLORE MR)

Impact of Myosin Inhibitors on Cardiac Remodeling in HCM: Different from Septal Reduction Therapies?

A Contemporary View on Pathophysiology and Clinical Significance of LVOT in HCM

SIEGEL TAVR: FIH 1 year & US Early Feasibility 30 Day Results

SESAME for the Treatment of Subaortic Membrane: First-in-Human Series

Advantages of Splitting Bicuspid Aortic Valve Leaflets Prior to TAVR: A New Paradigm for Leaflet Modification in BAV?

BONAPART: A Novel Mechanical Leaflet Splitting Device

The Evolution of Leaflet Modification Technologies: Emerging Techniques (e.g. UNICORN, BATMAN, etc), Technologies and Future Applications

M-TEER for Atrial and Ventricular SMR: Insights from the REPAIR Study

Clipping Strategies and Outcomes in Atrial SMR Patients Treated with the MitraClip System

Effect of TTVR on Preference-Weighted Health Status: A Patient-Centered Sub-Study of the TRISCEND II Pivotal Trial

Early Outcomes of Real-World TTVR (Evoque)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content